Characterization of E2F3a function in HepG2 liver cancer cells

Journal of Cellular Biochemistry

Volumn 111, Issue 5, 2010, Pages 1244-1251

  Li, Wei ^a   Ni, Guo Xin ^a   Zhang, Ping ^a   Zhang, Zheng Xi ^a   Wu, Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

apoptosis; cell cycle; E2F3a; HCC; HepG2; transcriptional regulation

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CLDN1 PROTEIN; KRUPPEL LIKE FACTOR 6; MESSENGER RNA; PROTEIN; STAT1 PROTEIN; TRANSCRIPTION FACTOR E2F3; TRANSCRIPTION FACTOR E2F3A; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; XIAP ASSOCIATED FACTOR 1;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION;

ANTIGENS, CD; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; CELL CYCLE; CELL PROLIFERATION; E2F3 TRANSCRIPTION FACTOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; RNA, MESSENGER;

EID: 78649821639     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22851     Document Type: Article

References (49)

1. Adams MR, Sears R, Nuckolls F, Leone G, Nevins JR,. 2000. Complex transcriptional regulatory mechanisms control expression of the E2F3 locus. Mol Cell Biol 20: 3633-3639.
2. Aslanian A, Iaquinta PJ, Verona R, Lees JA,. 2004. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev 18: 1413-1422.
3. Asp P, Acosta-Alvear D, Tsikitis M, van Oevelen C, Dynlacht BD,. 2009. E2F3b plays an essential role in myogenic differentiation through isoform-specific gene regulation. Genes Dev 23: 37-53.
4. Bracken AP, Ciro M, Cocito A, Helin K,. 2004. E2F target genes: Unraveling the biology. Trends Biochem Sci 29: 409-417.
5. Chen D, Pacal M, Wenzel P, Knoepfler PS, Leone G, Bremner R,. 2009a. Division and apoptosis of E2F-deficient retinal progenitors. Nature 462: 925-929.
6. Chen HZ, Tsai SY, Leone G,. 2009b. Emerging roles of E2Fs in cancer: An exit from cell cycle control. Nat Rev Cancer 9: 785-797.
7. Chong JL, Tsai SY, Sharma N, Opavsky R, Price R, Wu L, Fernandez SA, Leone G,. 2009a. E2F3a and E2F3b contribute to the control of cell proliferation and mouse development. Mol Cell Biol 29: 414-424.
8. Chong JL, Wenzel PL, Saenz-Robles MT, Nair V, Ferrey A, Hagan JP, Gomez YM, Sharma N, Chen HZ, Ouseph M, Wang SH, Trikha P, Culp B, Mezache L, Winton DJ, Sansom OJ, Chen D, Bremner R, Cantalupo PG, Robinson ML, Pipas JM, Leone G,. 2009b. E2F1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature 462: 930-934.
9. Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS,. 2000. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis. Oncogene 19: 5054-5062.
10. De Meyer T, Bijsmans IT, Van de Vijver KK, Bekaert S, Oosting J, Van Criekinge W, van Engeland M, Sieben NL,. 2009. E2Fs mediate a fundamental cell-cycle deregulation in high-grade serous ovarian carcinomas. J Pathol 217: 14-20.
11. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR,. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 94: 7245-7250.
12. Dimova DK, Dyson NJ,. 2005. The E2F transcriptional network: Old acquaintances with new faces. Oncogene 24: 2810-2826.
13. Dynlacht BD,. 1997. Regulation of transcription by proteins that control the cell cycle. Nature 389: 149-152.
14. Dyson N,. 1998. The regulation of E2F by pRB-family proteins. Genes Dev 12: 2245-2262.
15. Feber A, Clark J, Goodwin G, Dodson AR, Smith PH, Fletcher A, Edwards S, Flohr P, Falconer A, Roe T, Kovacs G, Dennis N, Fisher C, Wooster R, Huddart R, Foster CS, Cooper CS,. 2004. Amplification and overexpression of E2F3 in human bladder cancer. Oncogene 23: 1627-1630.
16. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin WG, Jr., Livingston DM, Orkin SH, Greenberg ME,. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85: 549-561.
17. Foster CS, Falconer A, Dodson AR, Norman AR, Dennis N, Fletcher A, Southgate C, Dowe A, Dearnaley D, Jhavar S, Eeles R, Feber A, Cooper CS,. 2004. Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene 23: 5871-5879.
18. Gonzalvez F, Ashkenazi A,. 2010. New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene 29: 4752-4765.
19. Hanahan D, Weinberg RA,. 2000. The hallmarks of cancer. Cell 100: 57-70.
20. He Y, Armanious MK, Thomas MJ, Cress WD,. 2000. Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region. Oncogene 19: 3422-3433.
21. Humbert PO, Verona R, Trimarchi JM, Rogers C, Dandapani S, Lees JA,. 2000. E2F3 is critical for normal cellular proliferation. Genes Dev 14: 690-703.
22. Hurst CD, Tomlinson DC, Williams SV, Platt FM, Knowles MA,. 2008. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification. Oncogene 27: 2716-2727.
23. Iaquinta PJ, Lees JA,. 2007. Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol 19: 649-657.
24. Kong LJ, Chang JT, Bild AH, Nevins JR,. 2007. Compensation and specificity of function within the E2F family. Oncogene 26: 321-327.
25. Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N, Helin K,. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 13: 7813-7825.
26. Leone G, Nuckolls F, Ishida S, Adams M, Sears R, Jakoi L, Miron A, Nevins JR,. 2000. Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins. Mol Cell Biol 20: 3626-3632.
27. Li J, Ran C, Li E, Gordon F, Comstock G, Siddiqui H, Cleghorn W, Chen HZ, Kornacker K, Liu CG, Pandit SK, Khanizadeh M, Weinstein M, Leone G, de Bruin A,. 2008. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev Cell 14: 62-75.
28. Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW, Korneluk RG,. 2001. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat Cell Biol 3: 128-133.
29. Liu LX, Jiang HC, Liu ZH, Zhu AL, Zhang WH, Wu LF, Zhou J, Wang XQ, Wu M,. 2003. Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues. Oncol Rep 10: 1771-1775.
30. Lukas J, Petersen BO, Holm K, Bartek J, Helin K,. 1996. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol Cell Biol 16: 1047-1057.
31. Maiti B, Li J, de Bruin A, Gordon F, Timmers C, Opavsky R, Patil K, Tuttle J, Cleghorn W, Leone G,. 2005. Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation. J Biol Chem 280: 18211-18220.
32. Martinez LA, Goluszko E, Chen HZ, Leone G, Post S, Lozano G, Chen Z, Chauchereau A,. 2010. E2F3 is a mediator of DNA damage-induced apoptosis. Mol Cell Biol 30: 524-536.
33. Müller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD, Helin K,. 2001. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 15: 267-285.
34. Mulligan G, Jacks T,. 1998. The retinoblastoma gene family: Cousins with overlapping interests. Trends Genet 14: 223-229.
35. Oeggerli M, Tomovska S, Schraml P, Calvano-Forte D, Schafroth S, Simon R, Gasser T, Mihatsch MJ, Sauter G,. 2004. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Oncogene 23: 5616-5623. (Pubitemid 39093039)
36. Olsson AY, Feber A, Edwards S, Te Poele R, Giddings I, Merson S, Cooper CS,. 2007. Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene 26: 1028-1037.
37. Paulson QX, McArthur MJ, Johnson DG,. 2006. E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model. Cell Cycle 5: 184-190.
38. Pierce AM, Schneider-Broussard R, Gimenez-Conti IB, Russell JL, Conti CJ, Johnson DG,. 1999. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol 19: 6408-6414.
39. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD,. 2002. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 16: 245-256.
40. Sherr CJ,. 1996. Cancer cell cycles. Science 274: 1672-1677.
41. Takahashi Y, Rayman JB, Dynlacht BD,. 2000. Analysis of promoter binding by the E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression. Genes Dev 14: 804-816.
42. Trimarchi JM, Lees JA,. 2002. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3: 11-20.
43. Tsai SY, Opavsky R, Sharma N, Wu L, Naidu S, Nolan E, Feria-Arias E, Timmers C, Opavska J, de Bruin A, Chong JL, Trikha P, Fernandez SA, Stromberg P, Rosol TJ, Leone G,. 2008. Mouse development with a single E2F activator. Nature 454: 1137-1141.
44. Weinberg RA,. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
45. Wells J, Boyd KE, Fry CJ, Bartley SM, Farnham PJ,. 2000. Target gene specificity of E2F and pocket protein family members in living cells. Mol Cell Biol 20: 5797-5807.
46. Wells J, Graveel CR, Bartley SM, Madore SJ, Farnham PJ,. 2002. The identification of E2F1-specific target genes. Proc Natl Acad Sci USA 99: 3890-3895.
47. Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP, Zhuang SM,. 2009. MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 50: 113-121.
48. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ,. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537-548.
49. Ziebold U, Reza T, Caron A, Lees JA,. 2001. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev 15: 386-391.